Profile data is unavailable for this security.
About the company
KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.
- Revenue in JPY (TTM)4.98bn
- Net income in JPY647.70m
- Incorporated1975
- Employees144.00
- LocationKainos Laboratories Inc2-38-18, HongoBUNKYO-KU 113-0033JapanJPN
- Phone+81 338164123
- Fax+81 338166550
- Websitehttp://www.kainos.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OncoTherapy Science, Inc. | 901.22m | -1.19bn | 4.03bn | 60.00 | -- | 5.97 | -- | 4.47 | -5.77 | -5.77 | 4.36 | 3.01 | 0.7589 | 5.31 | 15.74 | 15,020,330.00 | -100.44 | -50.21 | -132.58 | -55.41 | -9.03 | -- | -132.35 | -331.97 | 3.29 | -258.18 | 0.00 | -- | -1.63 | 39.97 | 56.50 | -- | -57.92 | -- |
| Perseus Proteomics Inc | 96.22m | -1.12bn | 4.07bn | 24.00 | -- | 2.53 | -- | 42.32 | -95.57 | -95.57 | 8.18 | 131.49 | 0.0424 | 1.82 | 11.22 | 4,009,083.00 | -49.52 | -33.51 | -51.65 | -34.95 | 89.01 | 93.09 | -1,168.66 | -470.63 | 17.58 | -- | 0.00 | -- | 30.96 | -20.89 | -31.38 | -- | 228.18 | -- |
| BrightPath Biotherapeutics Co Ltd | 118.00k | -1.21bn | 4.24bn | 32.00 | -- | 5.03 | -- | 35,970.15 | -19.27 | -19.27 | 0.0019 | 11.92 | 0.00007 | -- | 0.0423 | 3,687.50 | -71.34 | -42.65 | -89.42 | -44.49 | -433.05 | 57.16 | -1,028,827.00 | -4,430.66 | -- | -875.45 | 0.3929 | -- | -65.73 | -56.89 | -0.0971 | -- | -56.39 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 788.12m | -192.71m | 4.28bn | 60.00 | -- | 3.90 | -- | 5.44 | -20.69 | -20.69 | 84.62 | 118.02 | 0.5144 | 0.8788 | 3.78 | 13,135,280.00 | -12.58 | -15.11 | -14.85 | -17.61 | 62.06 | 56.66 | -24.45 | -50.04 | 3.49 | 0.494 | 0.1774 | -- | 22.71 | 0.9405 | -11.97 | -- | -- | -- |
| Renascience Inc | 191.32m | -331.66m | 4.44bn | 3.00 | -- | 2.70 | -- | 23.19 | -26.09 | -26.09 | 15.05 | 129.22 | 0.0851 | -- | -- | 63,772,000.00 | -14.74 | -- | -15.49 | -- | 85.75 | -- | -173.36 | -- | -- | -- | 0.1782 | -- | -27.84 | -- | -32.05 | -- | -- | -- |
| MEDRx Co Ltd | 29.53m | -932.90m | 4.63bn | 22.00 | -- | 2.25 | -- | 156.74 | -27.24 | -27.24 | 0.8492 | 50.17 | 0.0171 | 0.2606 | 1.22 | 1,342,455.00 | -54.07 | -58.15 | -58.45 | -62.23 | 91.87 | 95.70 | -3,158.72 | -1,526.17 | 17.75 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| Solasia Pharma KK | 617.00m | -1.11bn | 5.21bn | 24.00 | -- | 2.50 | -- | 8.45 | -6.61 | -6.61 | 3.67 | 10.78 | 0.2301 | 4.10 | 1.93 | 25,708,330.00 | -41.51 | -48.57 | -47.74 | -58.83 | 54.78 | 71.01 | -180.39 | -300.89 | 2.91 | -- | 0.031 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| Kidswell Bio Corp | 2.62bn | -1.21bn | 5.36bn | 41.00 | -- | 3.62 | -- | 2.05 | -37.72 | -37.72 | 77.56 | 37.57 | 0.5583 | 1.26 | 4.00 | 63,807,830.00 | -25.82 | -58.77 | -36.65 | -77.44 | 50.30 | 59.87 | -46.25 | -139.31 | 1.86 | -21.98 | 0.6118 | -- | 76.92 | 21.24 | -22.83 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 4.98bn | 647.70m | 5.51bn | 144.00 | 7.80 | 0.8237 | 7.14 | 1.10 | 154.88 | 154.88 | 1,192.40 | 1,466.62 | 0.605 | 2.89 | 3.13 | 34,615,160.00 | 7.86 | 6.66 | 10.25 | 9.07 | 51.41 | 51.52 | 12.99 | 9.89 | 2.53 | -- | 0.1133 | 17.01 | 6.69 | 2.33 | 10.90 | 15.37 | -46.23 | 14.87 |
| Cyfuse Biomedical KK | 61.11m | -589.21m | 5.59bn | 21.00 | -- | 1.74 | -- | 91.45 | -75.45 | -75.45 | 7.82 | 405.80 | 0.0135 | 0.5407 | 3.98 | 2,910,095.00 | -13.05 | -- | -15.34 | -- | 61.76 | -- | -964.15 | -- | 5.92 | -71.55 | 0.2218 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| Delta-Fly Pharma Inc | 0.00 | -1.26bn | 6.08bn | 11.00 | -- | 3.60 | -- | -- | -187.93 | -187.93 | 0.00 | 205.25 | 0.00 | -- | -- | 0.00 | -92.45 | -53.35 | -103.56 | -55.60 | -- | -- | -- | -769.75 | -- | -391.17 | 0.00 | -- | -100.00 | -- | -37.37 | -- | -- | -- |
| CellSeed Inc | 190.13m | -846.53m | 6.76bn | 35.00 | -- | 3.05 | -- | 35.53 | -29.28 | -29.28 | 6.61 | 68.81 | 0.0948 | 1.62 | 4.90 | 5,432,400.00 | -42.22 | -49.69 | -45.69 | -54.55 | 56.36 | 63.66 | -445.23 | -428.62 | 18.66 | -601.01 | 0.0653 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Noile-Immune Biotech Inc | 316.82m | -1.13bn | 6.84bn | 28.00 | -- | 1.20 | -- | 21.59 | -26.14 | -26.14 | 7.32 | 131.42 | 0.0608 | 0.1818 | -- | 11,314,930.00 | -21.69 | -- | -22.60 | -- | 99.29 | -- | -356.68 | -- | 66.04 | -- | 0.00 | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| NIPPON CHEMIPHAR CO., LTD. | 30.61bn | -241.00m | 6.86bn | 872.00 | -- | 0.31 | 5.74 | 0.2241 | -66.77 | -66.77 | 8,482.42 | 5,194.10 | 0.6063 | 2.09 | 2.65 | 35,106,650.00 | -0.4793 | 1.20 | -0.6777 | 1.74 | 25.09 | 34.53 | -0.7905 | 1.77 | 1.61 | -- | 0.4852 | 38.20 | -2.91 | -2.23 | -51.57 | -21.81 | -13.06 | -12.94 |
| Chiome Bioscience Inc | 682.46m | -1.22bn | 6.90bn | 51.00 | -- | 5.59 | -- | 10.11 | -24.67 | -24.67 | 13.77 | 22.00 | 0.3441 | 4.19 | 6.88 | 13,381,650.00 | -61.51 | -50.50 | -79.81 | -57.38 | 58.41 | 57.53 | -178.77 | -224.74 | 2.90 | -513.93 | 0.2009 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| Carna Biosciences, Inc. | 1.63bn | -1.15bn | 7.00bn | 67.00 | -- | 1.80 | -- | 4.30 | -69.84 | -69.84 | 96.78 | 226.16 | 0.3774 | 1.36 | 3.35 | 24,267,000.00 | -26.76 | -14.45 | -29.55 | -16.95 | 89.22 | 90.59 | -70.91 | -35.42 | 10.78 | -312.97 | 0.0451 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
Data as of May 02 2024. Currency figures normalised to Kainos Laboratories Inc's reporting currency: Japanese Yen JPY
1.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lemanik Invest SAas of 29 Feb 2024 | 48.00k | 1.05% |
| Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 200.00 | 0.00% |
Data from 29 Feb 2024 - 19 Apr 2024Source: FactSet Research Systems Inc.
